Drug Trial Radar · NCT01954394
Open Label Study of Long Term Safety Evaluation of Alirocumab
Last checked: Nov 20, 2026Latest source record: Jul 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
986
Actual
Start
Dec 17, 2013
Primary completion
Jun 30, 2017
Study completion Jun 30, 2017
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Regeneron Pharmaceuticals
- First posted
- Oct 1, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To assess the long-term safety of alirocumab (SAR236553/REGN727) when added to lipid-lowering therapy in participants with heterozygous familial hypercholesterolemia (heFH) who had completed EFC12492 (NCT01623115), R727-CL-1112 (NCT01709500), EFC12732 (NCT01617655) and LTS11717 (NCT01507831). Secondary Objectives: * To evaluate the long-term efficacy of alirocumab on lipid parameters. * To evaluate the long-term immunogenicity of alirocumab.
Conditions
- Hypercholesterolemia
Interventions
AlirocumabDrug
Solution for injection, one subcutaneous injection in the abdomen, thigh, or outer area of upper arm with a pre-filled syringe.
Lipid-Modifying Therapy (LMT)Drug
Statin (rosuvastatin, simvastatin or atorvastatin) at stable dose with or without other LMT as clinically indicated.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Experienced Adverse Events (AEs)Time frame: Up to 10 weeks after last study drug administration (maximum of 176 weeks)
Locations
177 sites in 24 countries. Site status is shown where the registry gives one.
Investigational Site Number 840321
Huntsville, Alabama
Investigational Site Number 840341
Tempe, Arizona
Investigational Site Number 840334
Bell Gardens, California
Investigational Site Number 840319
Fountain Valley, California
Investigational Site Number 840336
Los Angeles, California
Investigational Site Number 840339
Mission Viejo, California
Investigational Site Number 840337
Newport Beach, California
Investigational Site Number 840306
Golden, Colorado
Investigational Site Number 840328
Washington D.C., District of Columbia
Investigational Site Number 840344
Atlantis, Florida
Investigational Site Number 840353
Clearwater, Florida
Investigational Site Number 840318
Fort Lauderdale, Florida
Investigational Site Number 840327
Jacksonville, Florida
Investigational Site Number 840309
Miami, Florida
Investigational Site Number 840351
Sarasota, Florida
Investigational Site Number 840315
Evanston, Illinois
Investigational Site Number 840305
Oakbrook Terrace, Illinois
Investigational Site Number 840333
Iowa City, Iowa
Investigational Site Number 840329
Kansas City, Kansas
Investigational Site Number 840345
Auburn, Maine
Investigational Site Number 840338
Biddeford, Maine
Investigational Site Number 840322
Boston, Massachusetts
Investigational Site Number 840346
Framingham, Massachusetts
Investigational Site Number 840317
St Louis, Missouri
Investigational Site Number 840349
St Louis, Missouri
Investigational Site Number 840314
Morristown, New Jersey
Investigational Site Number 840316
New York, New York
Investigational Site Number 840324
Poughkeepsie, New York
Investigational Site Number 840303
Charlotte, North Carolina
Investigational Site Number 840320
Durham, North Carolina
Investigational Site Number 840348
Raleigh, North Carolina
Investigational Site Number 840340
Cincinnati, Ohio
Investigational Site Number 840302
Marion, Ohio
Investigational Site Number 840330
Portland, Oregon
Investigational Site Number 840352
Beaver, Pennsylvania
Investigational Site Number 840308
Philadelphia, Pennsylvania
Investigational Site Number 840342
Scranton, Pennsylvania
Investigational Site Number 840304
Summerville, South Carolina
Investigational Site Number 840311
Dallas, Texas
Investigational Site Number 840312
Dallas, Texas
Showing 40 of 177 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.